Share
𝕏 Facebook LinkedIn

A study of the effects of pulsed electromagnetic field therapy with respect to serological grouping in rheumatoid arthritis.

PAPER pubmed Journal of the Indian Medical Association 1998 Unknown Effect: mixed Evidence: Insufficient

Abstract

The positive role of pulsed electromagnetic field (PEMF) therapy in rheumatoid arthritis (RA) is known. The differential role of serological status of patients in RA is also well known. This paper presents a study of the differential effects of PEMF therapy on the two serological groups of patients. The responses of the seropositive patients are found to be more subdued. Varying effects of the therapy in alleviating the different symptomatologies indicate that the rheumatoid factor (RF) is more resistant to PEMF.

AI evidence extraction

At a glance
Study type
Unknown
Effect direction
mixed
Population
Patients with rheumatoid arthritis (RA), including seropositive and seronegative groups
Sample size
—
Exposure
pulsed electromagnetic field (PEMF) therapy
Evidence strength
Insufficient
Confidence: 62% · Peer-reviewed: yes

Main findings

The study reports differential effects of PEMF therapy between serological groups in RA. Responses in seropositive patients were described as more subdued, and varying effects across symptoms suggested rheumatoid factor may be more resistant to PEMF.

Outcomes measured

  • Differential response to PEMF therapy by serological status (seropositive vs seronegative)
  • Symptom alleviation in RA
  • Rheumatoid factor (RF) response/resistance to PEMF

Limitations

  • Study design not described in abstract
  • Sample size not reported
  • Exposure parameters (frequency, intensity, duration) not reported
  • Outcome measures and statistical methods not reported

Suggested hubs

  • clinical-therapeutic-emf (0.78)
    Study evaluates PEMF therapy effects in a clinical condition (rheumatoid arthritis).
View raw extracted JSON
{
    "study_type": "unknown",
    "exposure": {
        "band": null,
        "source": "pulsed electromagnetic field (PEMF) therapy",
        "frequency_mhz": null,
        "sar_wkg": null,
        "duration": null
    },
    "population": "Patients with rheumatoid arthritis (RA), including seropositive and seronegative groups",
    "sample_size": null,
    "outcomes": [
        "Differential response to PEMF therapy by serological status (seropositive vs seronegative)",
        "Symptom alleviation in RA",
        "Rheumatoid factor (RF) response/resistance to PEMF"
    ],
    "main_findings": "The study reports differential effects of PEMF therapy between serological groups in RA. Responses in seropositive patients were described as more subdued, and varying effects across symptoms suggested rheumatoid factor may be more resistant to PEMF.",
    "effect_direction": "mixed",
    "limitations": [
        "Study design not described in abstract",
        "Sample size not reported",
        "Exposure parameters (frequency, intensity, duration) not reported",
        "Outcome measures and statistical methods not reported"
    ],
    "evidence_strength": "insufficient",
    "confidence": 0.61999999999999999555910790149937383830547332763671875,
    "peer_reviewed_likely": "yes",
    "keywords": [
        "pulsed electromagnetic field",
        "PEMF",
        "rheumatoid arthritis",
        "seropositive",
        "seronegative",
        "rheumatoid factor"
    ],
    "suggested_hubs": [
        {
            "slug": "clinical-therapeutic-emf",
            "weight": 0.7800000000000000266453525910037569701671600341796875,
            "reason": "Study evaluates PEMF therapy effects in a clinical condition (rheumatoid arthritis)."
        }
    ]
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract/metadata and may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.